mycophenolaatmofetil

Mycophenolate mofetil is an immunosuppressant medication used to prevent organ rejection after a transplant and to treat certain autoimmune diseases. It is a prodrug of mycophenolic acid. Mycophenolate mofetil works by inhibiting the proliferation of lymphocytes, particularly T-cells and B-cells, which are key components of the immune system involved in rejecting foreign tissues and attacking the body's own cells in autoimmune conditions.

The medication is typically administered orally or intravenously. It is often used in combination with other immunosuppressants such as corticosteroids and calcineurin inhibitors. Common uses include preventing kidney, heart, and liver transplant rejection. It is also used in the management of conditions like lupus nephritis and rheumatoid arthritis.

Like all medications, mycophenolate mofetil can cause side effects. The most common side effects include gastrointestinal disturbances such as diarrhea, nausea, and vomiting, as well as blood disorders like anemia and leukopenia. It can also increase the risk of infections due to its immunosuppressive nature. Other potential side effects include headache, tremors, and skin reactions.

Mycophenolate mofetil requires careful monitoring by a healthcare professional to manage its dosage and monitor for adverse effects. It is contraindicated in patients with a known hypersensitivity to the drug. Women who are pregnant or breastfeeding should not use mycophenolate mofetil due to potential risks to the fetus or infant.